Insulin Resistance
1,033
74
109
691
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
112 trials with published results (11%)
Research Maturity
691 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.1%
53 terminated out of 1033 trials
92.9%
+6.4% vs benchmark
10%
104 trials in Phase 3/4
16%
112 of 691 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 691 completed trials
Clinical Trials (1033)
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Everolimus Aging Study
Ertugliflozin: Cardioprotective Effects on Epicardial Fat
Exercise Effects on Adipose Tissue Structure and Function
Food and Metabolism Study
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Identifying Risk for Diabetes and Heart Disease in Women
Cross-Sectional and Longitudinal Studies of "Pre-Diabetes" in the Pima Indians
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV
Graded Insulin Suppression Test P&F
Validation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 Diabetes
Metabolic Effects of Angiotensin-(1-7)
Precision Diets for Diabetes Prevention
Role of Aging and Individual Variation in Exercise Training Responsiveness
PREdiabetes GLycemic Impact and Data Evaluation
Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin Resistance